InvestorsHub Logo
Followers 22
Posts 1431
Boards Moderated 0
Alias Born 08/17/2009

Re: Aksys post# 4946

Tuesday, 02/07/2012 6:21:15 PM

Tuesday, February 07, 2012 6:21:15 PM

Post# of 48223
BOCA RATON, FLORIDA, Jan 10, 2012 (MARKETWIRE via COMTEX) -- Allezoe Medical Holdings, Inc. (OTCBB: ALZM) announced that it has entered into an agreement to acquire the decontamination technology licensing and development business of BioCube, Inc. (OTCBB: BICB) in exchange for convertible preferred stock of Allezoe plus the cancellation of the existing 60 percent non-dilution provision relating to the Company's common stock, issued in connection with the acquisition of Organ Transport Systems, Inc. The preferred stock to be issued will carry a 51 percent of the shareholder vote and will be convertible after one year at the discretion of the holder into 51 percent of the common stock. The transaction will be completed in the next 30 days through the acquisition of a wholly-owned Nevada subsidiary of BioCube.